CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Lomitapide

Last Updated: July 8, 2014
Result type: Reports
Project Number: SR0386-000
Product Line: Reimbursement Review

Generic Name: Lomitapide

Brand Name: Juxtapid

Manufacturer: Aegerion Pharmaceuticals (Canada) Ltd.

Indications: Hypercholesterolemia, Homozygous Familial

Submission Type: Initial

Project Status: Complete

Date Recommendation Issued: April 17, 2015

Recommendation Type: Do not list